Jasper Therapeutics, Inc. - Class A Common Stock (JSPR)

Jasper Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapeutics to address critical unmet medical needs, particularly in the fields of hematology and oncology

The company is committed to advancing transformative therapies that enhance patient outcomes and improve the quality of life through cutting-edge research and development. Jasper Therapeutics leverages its proprietary technologies and expertise to create novel treatments that aim to tackle complex diseases, fostering collaborations to expedite the delivery of its breakthroughs to patients in need.